6.10
Finanzdaten der Atea Pharmaceuticals Inc-Aktie (AVIR)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
-
|
- | - | - | - |
|
|
20.56%
54.93
|
45.57 | 41.34 | 39.04 | 39.03 |
| Depreciation and Amortization |
0.00%
0.104
|
0.104 | 0.104 | 0.104 | 0.104 |
| Operating Income/Loss |
20.56%
-54.93
|
-45.57 | -41.34 | -39.04 | -39.03 |
| Income/Loss From Continuing Operations Before Tax |
23.37%
-51.63
|
-41.85 | -36.95 | -34.07 | -33.32 |
| Income Tax Expense/Benefit |
3,553%
-6.768
|
0.196 | 0.207 | 0.203 | 0.225 |
| Income/Loss From Continuing Operations After Tax |
6.70%
-44.87
|
-42.05 | -37.16 | -34.27 | -33.54 |
|
|
6.70%
-44.87
|
-42.05 | -37.16 | -34.27 | -33.54 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
101.43%
-1.1285
|
79.05 | 83.75 | 85.16 | 0.0666 |
| Diluted Average Shares |
101.43%
-1.1285
|
79.05 | 83.75 | 85.16 | 0.0666 |
| Basic Earnings Per Share |
7.55%
-0.57
|
-0.53 | -0.44 | -0.40 | -0.40 |
| Diluted Earnings Per Share |
7.55%
-0.57
|
-0.53 | -0.44 | -0.40 | -0.40 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):